ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2676

Reduction of Dlco and FVC in Patients with GERD and Systemic Sclerosis

Rodrigo Aguila Maldonado1, Pierina Sansinanea2, Claudia Elizabeth Pena1, Ana Carolina Costi1, Ariel Vulcano2, Adriana Testi2, Mariana Pera3, Lucila García2, Valeria Arturi3, Viviana Nagua2 and Mercedes Garcia1, 1Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 2Rheumatology, HIGA General San Martin La Plata, la plata, Argentina, 3HIGA General San Martin La Plata, la plata, Argentina

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Gastrointestinal complications and systemic sclerosis, Pulmonary Involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Esophageal involvement is common in Systemic Sclerosis (SSc). It is estimated to occur in 70-90% of patients. Esophageal motor dysfunction is characterized by hypotonia of lower esophageal sphincter (LES) and mild peristalsis or aperistalsis in 2/3 of the esophagus. There is evidence that interstitial lung disease (ILD) and pulmonary fibrosis in SSc are associated with episodes of microaspirations secondary to gastroesophageal reflux disease (GERD).
The aim of this study was to determine if GERD is associated with ILD in SSc patients.

Methods: An observational retrospective cohort study was conducted during the period 1983-2016 in a single hospital centre. Diagnosis of GERD was established by typical clinical symptoms of heartburn and regurgitation. Esophageal manometry was performed to evaluate motility and was classified as: hypotensive LES (<10mmHg) and ineffective or absence of peristalsis at the distal esophagus. Pulmonary involvement was performed by high resolution computed tomography. Pulmonary function tests were performed with carbon monoxide diffusing capacity (DLCO) and forced vital capacity (FVC). Demographic, serological, clinical, and respiratory functional tests were analyzed. For quantitative and qualitative variables, Student’s T, Mann-Whitney, and Chi-2 were used, respectively. The hazard ratio values were obtained with a 95% confidence interval. Values of p≤0.05 were considered statistically significant.

Results: 125 patients with SSc were included, of whom 91 (72.8%) had GERD, with female predominance in both groups. Comparatively between the groups that presented GERD and those that did not, the age at diagnosis was similar and the time of evolution of the disease was 7 years vs 2 (p <0.001) respectively. In terms of disease subtypes, no statistically significant differences were found between patients with GERD and those who did not. Among the clinical characteristics analyzed, the presence of GER was not associated with cardiac involvement while it was for digital ulcers (36/91 vs 4/34; p=0.003). There were no significant differences in the immunological profile. The decrease in DLCO <70% and FVC <70% were more frequent in patients with GERD (49.4% vs 23.5%, 47.2% vs 23.5%; p=0.009). Alterations in esophageal manometry were more frequent in patients with GERD 59.34% (p=0.035) All data are detailed in the table below.

Conclusion: Significant differences were found when evaluating complementary studies such as DLCO <70%, FVC <70% and esophageal manometry, indicating that there is an association between GERD and ILD. A statistically significant finding was the association between the presence of digital ulcers and the presence of GERD.

Patients with GERD (91)

Patients without GERD (34)

P

OR (IC 95%)

Age at diagnosis (years)

47,5±15

48±15

0,84

0,85 (-5,47- 6,64)

Evolution (years)

7 (2-11)

2 (1-5)

< 0,001

–

Gender Male

Female

12

79

6

28

0,003

4,9 (1,59-15,1)

Diffuse type

33

9

0,302

1,58 (0,66-3,79)

Limited type

57

25

0,254

0,6 (0,52-1,44)

DLCO < 70%

45

8

0,009

3,18 (1,39-7,76)

FVC < 70%

43

8

0,016

2,91 (1,19-7,11)

Manometry:

Hypotensive LES / aperistalsis

54

13

0,035

2,36 (1,05-5,29)

Digital Ulcers

36

4

0,003

4,91(1,59-5,12)

Cardiac involvement

44

16

0,898

1,05 (0,48-2,13)

Anti scl70

21

4

0,159

2,25 (0,71-7,12)

Anti centromere

37

17

0,348

0,69 (0,31-1,51)


Disclosure: R. Aguila Maldonado, None; P. Sansinanea, None; C. E. Pena, None; A. C. Costi, None; A. Vulcano, None; A. Testi, None; M. Pera, None; L. García, None; V. Arturi, None; V. Nagua, None; M. Garcia, None.

To cite this abstract in AMA style:

Aguila Maldonado R, Sansinanea P, Pena CE, Costi AC, Vulcano A, Testi A, Pera M, García L, Arturi V, Nagua V, Garcia M. Reduction of Dlco and FVC in Patients with GERD and Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/reduction-of-dlco-and-fvc-in-patients-with-gerd-and-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduction-of-dlco-and-fvc-in-patients-with-gerd-and-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology